A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease
Overview
Authors
Affiliations
Background: This study aimed to evaluate the feasibility, acceptability, and effectiveness of a mindfulness-based intervention for patients with inflammatory bowel disease (MI-IBD).
Design: Treatment-as-usual control versus mindfulness-based stress reduction intervention.
Methods: Sixty patients participated in either the MI-IBD (n = 33) or treatment-as-usual group (n = 27) conditions. The MI-IBD consisted of an 8-week mindfulness-based stress reduction training group. Outcome measures were administered at baseline (before intervention), immediately after intervention, and 6 months after intervention. Primary outcomes included measures of quality of life, psychological distress (depression and anxiety), and mindfulness. Data for MI-IBD group participants also included weekly attendance, daily minutes meditated, and satisfaction with the program.
Results: There were no baseline differences between intervention and control groups on demographic variables or inflammatory bowel disease severity. Compared with the control group, the MI-IBD group reported significantly greater improvements in anxiety, quality of life, and mindfulness at after intervention, with reduction in depression and improvements in quality of life and mindfulness maintained at 6 months after intervention.
Conclusions: Results demonstrate the feasibility, acceptability, and efficacy of a mindfulness intervention for patients with inflammatory bowel disease, with medium-to-large effects on psychological distress, quality of life, and mindfulness.
Schlee C, Uecker C, Oznur O, Bauer N, Langhorst J PLoS One. 2024; 19(11):e0313127.
PMID: 39536026 PMC: 11559982. DOI: 10.1371/journal.pone.0313127.
Qian X, Zhang J Actas Esp Psiquiatr. 2024; 52(4):571-582.
PMID: 39129703 PMC: 11319758. DOI: 10.62641/aep.v52i4.1559.
Davies J, Teh J, Ewais T, Begun J Inflamm Bowel Dis. 2024; 30(12):2428-2439.
PMID: 38839073 PMC: 11630472. DOI: 10.1093/ibd/izae121.
Chappell K, Meakins D, Marsh-Joyal M, Bihari A, Goodman K, Le Melledo J JMIR Form Res. 2024; 8:e53550.
PMID: 38709548 PMC: 11106704. DOI: 10.2196/53550.
Psychological burden and quality of life in newly diagnosed inflammatory bowel disease patients.
Bernabeu P, Belen-Galipienso O, van-der Hofstadt C, Gutierrez A, Madero-Velazquez L, Garcia Del Castillo G Front Psychol. 2024; 15:1334308.
PMID: 38348263 PMC: 10859525. DOI: 10.3389/fpsyg.2024.1334308.